The 340B Program is a federal drug pricing program that allows certain hospitals, clinics, and other safety-net healthcare providers — generally those serving low-income or uninsured populations — to purchase outpatient prescription drugs at reduced prices. The savings are intended to help these “covered entities” stretch limited resources further while serving vulnerable patients.
Pharmacies enter the picture because covered entities often rely on an in-house pharmacy or a contracted outside pharmacy to actually dispense 340B-purchased drugs to patients. That arrangement comes with its own layer of program integrity rules around how 340B inventory is tracked, kept separate from regular purchasing, and reported, distinct from the everyday practice-of-pharmacy rules a state board enforces.
Why it matters
A pharmacist working for or with a 340B covered entity encounters the program mainly through inventory management, dispensing workflow, and documentation practices designed to keep 340B-priced drugs auditable and separate from non-340B stock. Because 340B is a federal pricing and eligibility program rather than a licensing scheme, participating doesn’t change a pharmacist’s underlying state licensure obligations — both sets of requirements apply at the same time.
Pharmacists new to a 340B setting often need to understand how the program’s compliance expectations layer on top of, rather than replace, standard pharmacy practice rules. RxByState tracks state-specific pharmacy practice requirements that apply alongside programs like 340B at app.rxbystate.com/signup.